Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponesimod in moderate to severe chronic plaque psoriasis
NCT01208090Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- Covalent Small Molecules, Molecular Glues, Classical Binding Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of ponesimod in plaque psoriasis, sponsored by Actelion Pharmaceuticals Ltd. Started Oct 2010; status: completed.
02
Drugs
ponesimod
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01208090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208090.